Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Respiratory Cell and Molecular Biology|November 19, 2011
Adiponectin pathway attenuates malignant mesothelioma cell growthKaijun Niu, Masanori Asada, Tatsuma Okazaki, et al.
The EMBO Journal|July 26, 2003
NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell deathSachiko Sakon, Xin Xue, Mutsuhiro Takekawa, et al.
EMBO Molecular Medicine|October 15, 2014
Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2Kamalika Mojumdar, Feng Liang, Christian Giordano, et al.
Experimental Gerontology|November 26, 2013
Coffee treatment prevents the progression of sarcopenia in aged mice in vivo and in vitroYinting Guo, Kaijun Niu, Tatsuma Okazaki, et al.
BMC Pulmonary Medicine|February 12, 2016
Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn's disease during infliximab therapyTadahisa Numakura, Tsutomu Tamada, Masayuki Nara, et al.
The Journal of Biological Chemistry|May 23, 2002
Identification of a novel transcriptional activator, BSAC, by a functional cloning to inhibit tumor necrosis factor-induced cell deathTomonari Sasazuki, Taisuke Sawada, Sachiko Sakon, et al.
Molecular Immunology|June 9, 2004
Genome wide analysis of TNF-inducible genes reveals that antioxidant enzymes are induced by TNF and responsible for elimination of ROSTomonari Sasazuki, Tatsuma Okazaki, Kurisu Tada, et al.
The American Journal of Pathology|May 16, 2009
alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammationTatsuma Okazaki, Amy Ni, Oluwasheyi A Ayeni, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 10, 2013
Royal jelly prevents the progression of sarcopenia in aged mice in vivo and in vitroKaijun Niu, Hui Guo, Yinting Guo, et al.
Oncoimmunology|February 5, 2019
Beneficial effects of sunitinib on tumor microenvironment and immunotherapy targeting death receptor5Yoko Tsukita, Tatsuma Okazaki, Satoru Ebihara, et al.
Pageof 7